Keynote Speakers of 2014 Symposium:

Robert McKennaRobert McKenna, MD, an internationally renowned hematopathologist, is Richard D. Brunning Professor & Director of Hematopathology at the University of Minnesota. He got his MD at the University of Minnesota in 1966, Internship at UCSD and Pathology Residency at University of Minnesota. He served as Assistant Professor, Associate Professor, and Professor at the University of Minnesota from 1974 to 1985, Professor and Director of Pathology Laboratories at University of Texas Southwestern Medical Center from 1985 to 1990, and Acting Chair and Executive Vice Chair of Pathology from 1990 to 2007. He was the President of Society for Hematopathology from 1992 to 1994, President of ASCP from 1996 to 1997, and President of American Board of Pathology in 2008. He has published over 150 peer reviewed papers and book chapters.

Keynote Presentation: Dr. McKenna

Dennis WeisenburgerDennis Weisenburger, MD, Chair and Professor of Pathology at the City of Hope, is an internationally renowned hematopathologist. He was awarded M.D. by the University of Minnesota in 1974 and had his pathology training at the University of Iowa and hematopathology fellowship training at the City of Hope. He was appointed as Assistant Clinical Professor at the University of California Davis from 1981 to 1984, Associate Professor of Pathology and Microbiology at University of Nebraska from 1984 to 1988, and Professor from 1988 to 2012. He has directed the Hematopathology Service and the Hematopathology Fellowship Program and led the well-known Nebraska Lymphoma Study Group at the University of Nebraska for 28 years before he came to City of Hope in 2012. He is an author of the WHO Classification of Hematopoietic and Lymphoid Neoplasms and he has published over 370 peer reviewed papers and book chapters.

Keynote Presentation: Dr. Weisenburger

Our Speakers:

Maher AlbitarMaher Albitar, MD, PhD, is the Chief Medical Officer and Director of Research and Development at NeoGenomics Laboratories. Previously, Dr. Albitar was the Medical Director of Hematology and Oncology and Director of Research and Development at Quest Diagnostic, Nichols Institute from 2003 to 2010. He was a tenured full professor at MD Anderson Cancer Center and the University of Texas prior to joining Quest Diagnostics. At MD Anderson Cancer Center, Dr. Albitar was the Director of the Molecular Laboratory and Leukemia Section from 1991 to 2003. He was trained in Anatomic and Clinical Pathology at Brown University and his fellowship training was in Hematopathology at the University of Pennsylvania. After finishing his hemtopathology training, he spent four years in a post-doctoral training in Genetic at the Howard Hughes Medical Institute at the University of Pennsylvania. Dr. Albitar has published more than 290 peer reviewed articles and multiple chapters and was the editor of two books. His work is focused on molecular characterization of cancer, particularly hematologic diseases and leukemias. He is the inventor of more than 20 patents and patent applications. He also served as a Director of Hematopathology fellowship program at MD Anderson Cancer and was the PI on numerous research programs and grants.

Presentation: Dr. Albitar

Jie-Gen JiangJie-Gen Jiang, MD, PhD got his medical training in Southern Medical University in China and his PhD in Department of Pathology, University of Pittsburgh School of Medicine (1997). After two years research fellowship, he stayed in Department of Pathology, University of Pittsburgh School of Medicine for another year as a Research Assistant Professor. His research in Pittsburgh focused on hepatocyte growth factor gene, a gene required for hepatocyte growth, liver regeneration, and cancer development. He did his residency training at Case Western Reserve University and Columbia University, and hematopathology fellowship at Columbia University (2004-2005). He worked at the CentraState Medical Center in New Jersey for two years before moving to Genoptix in San Diego in 2008. He is currently a senior hematopathologist at Genoptix, covering hematopathology, surgical pathology consultation, and molecular pathology in solid tumors.

Presentation: Dr. Jiang

Arash MohtashamianArash Mohtashamian, MD, CDR, MC, USN is Director of Pathology Residency Program and a staff Hematopathologist at the Naval Medical Center, San Diego (NMCSD). Dr. Mohtashamian received his MD from Medical College of Wisconsin, completed his residency training at Walter Reed National Medical Center, and his fellowship training at Northwestern Memorial Hospital. Dr. Mohtashamian’s interest include all areas of hematopathology, but more specifically pediatric hematopathology and bone marrow manifestations of non-neoplastic disorders. He is a Clinical Investigator for Children’s Oncology Group (COG) and is engaged on various research projects pertaining to the role of infectious and inflammatory causes in human cancer with Sanford-Burnham Medical Research Institute.

Presentation: Dr. Mohtashamian

Bruce RobbinsBruce Robbins, MD graduated from Stanford University in 1975 and from UCSD School of Medicine in 1980. He completed his anatomic and clinical pathology residency training at Mercy Hospital and Medical Center in 1984, followed by a fellowship in immunopathology at Scripps Clinic in 1984-85. Dr. Robbins worked as a staff pathologist for 13 years at Scripps Clinic prior to joining SDPMG in 1998. Dr. Robbins has extensive research experience and is an author of many original researches. He is board certified in Anatomic Pathology, Clinical Pathology, Hematopathology and Immunopathology. He has extensive experience with lymph node and bone marrow pathology, immunohistochemistry and flow cytometry.

Presentation: Dr. Robbins

Keith ThompsonKeith Thompson, MD, CDR, USN is Medical Director of Hematology/Coagulation and Associate Residency Program Director at the Naval Medical Center San Diego (NMCSD). After earning a B.S. at the College of William and Mary and an M.D. at the Medical College of Virginia, Dr. Thompson completed an internal medicine internship at the Naval Medical Center in Portsmouth, Virginia. He then completed tours as a Battalion Surgeon at 2nd Bn, 8th Marines at Camp Lejeune and as a mountaineering/cold weather medicine instructor at the Marine Corps Mountain Warfare Training Center. Upon finishing a pathology residency at NMCSD, he became the Laboratory Medical Director at the Naval Hospital in Yokosuka Japan. After completing a hematopathology fellowship at the Scripps Green Clinic, he came to NMCSD in his current position. Dr. Thompson has been awarded the NMCSD Pathology Educator of the Year for academic years 2012-2013 and 2013-2014.

Presentation: Dr. Thompson

Huan-You WangHuan-You Wang, M.D., Ph.D. is Clinical Professor of Pathology, Director of Hematopathology Fellowship Program, and Co-Director of Hematopathology at the UCSD Department of Pathology. After his medical training at Tongji Medical University, Dr. Wang was recruited to Peking University as an Instructor of Pathology. He got his Ph.D. at the UCSD Molecular Pathology program, and subsequently had his Anatomic and Clinical Pathology Training at the University of Virginia. Upon his finishing Hematopathology fellowship at the University of Pennsylvania, he accepted a faculty position at UT Southwestern Medical Center, where he worked for 4 years with Dr. Robert McKenna. During this period, he served as Director of Hematology and Bone Marrow Lab at Parkland Memorial Hospital and Clinics, and Director of Molecular Genetics Pathology fellowship. Dr. Wang returned to UCSD in 2009 and served as Co-Director of Hematopathology ever since. Together with his colleague, he established the ACGME-accredited UCSD Hematopathology Fellowship program. Dr. Wang's practice includes benign and malignant disorders involving blood, bone marrow, lymph node, and lymphoid tissue. In addition, he is also interested in flow cytometry, molecular and cytogenetic hematopathology.

Presentation: Dr. Wang (Pending)

Yin XuYin Xu, MD, PhD is the Director of Hematopathology at Genoptix Medical Laboratory, a Novartis company. She received her MD degree from the University of Heidelberg, Germany and her PhD. in Molecular Pathology at the University of New Mexico. Dr. Xu completed her Anatomic and Clinical Pathology Residency and Hematopathology Fellowship under Dr. Robert McKenna at the University of Texas Southwestern Medical Center. She was a Hematopathology Faculty at University of Minnesota and UT Southwestern Medical Center before moving to Southern California. Her specialties include Flow Cytometry and Bone Marrow Pathology, with many peer reviewed publications in those areas.

Presentation: Dr. Xu

Our Organizing Committee:

John Adamson, MD Professor & Chief, Hematology & Oncology Section, UCSD/VAMC
Kelly Bethel, MD, Director, Hematopathology Fellowship, Scripps Green Hospital
H. Elizabeth Broome, MD, Professor & Director, Hematology Lab, CALM of UCSD
Steven Gonias, MD, PhD, Professor & Chairman, Department of Pathology, UCSD
Anand Kunda, MD, Staff Pathologist, Sharp Memorial Hospital
Jie-Gen Jiang, MD, PhD, Senior Hematopathologist, Genoptix Medical Laboratory
Arash Mohtashamian, MD, CDR MC USN, Staff Hematopathologist & Residency Program Director, Naval Medical Center
Robert Sharpe, MD,, Professor & Senior Staff Hematopathologist, UCSD/Scripps Green Hospital
Huan-You Wang, MD, PhD, Professor & Director, Hematopathology Fellowship, UCSD
Jessica Wang-Rodriguez, MD, Professor & Chief, PALMS, UCSD/VAMC
Xiangdong (Don) Xu, MD, PhD, Assistant Professor, UCSD/VAMC
Frank Zhao, MD, PhD, MBA, Professor & Chief, Hematopathology, UCSD/VAMC (Program Director)

It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest have been resolved prior to this educational activity.